SK Hynix Inc (000660)
Korea Exchange · Korea · prices in KRW · close of 27 Oct 2026
Key indicators
| Last close | KRW 1,341,000.00 |
|---|---|
| 52-week range | 501,000.00 – 2,987,000.00 |
| Return, 1 month / 3 months | −28.0% / −26.1% |
| Return, 1 year / 3 years | +151.4% / +1,047.9% |
| Trend | Below its 200-day average |
| RSI (14) | 39 |
| Volatility (1 year) | 90.7% |
| Worst drawdown (1 year) | -58.1% |
| Average daily value traded | 6,392,752.44M KRW |
| Dividend yield | 0.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
SK Hynix Inc is a South Korean semiconductor company based in Icheon. It designs and manufactures memory chips, chiefly dynamic random access memory and flash memory, which are used to store and move data in computers, smartphones, servers and other electronic devices. Its customers are device makers and data centre operators around the world who need memory components for their products and systems. The company also supplies advanced memory products for high-bandwidth computing applications.
On this site SK Hynix Inc appears as a stock on the Korea Exchange (Korea), code 000660, with prices in South Korean won (KRW). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
SK Hynix Inc (000660) trades on the Korea Exchange in Korea. It last closed at KRW 1,341,000.00 on 27 October 2026.
Its price-based Market X-Ray is 56 out of 100 (a fair price profile), ranking 378 of 934 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 151.4% and over the last three months it fell 26.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Korea Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 60 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -9.4% | ||
| From 52-week high | -54.1% | ||
| Momentum | 66 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -26.1% | ||
| 6-month return | 3.8% | ||
| 12-month return, skipping the last month | 249.1% | ||
| Stability (higher is calmer) | 17 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 90.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -58.1% | ||
| Liquidity | 100 · Strong | Trades actively. | |
| Average daily value traded | 6,392,752.44M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | 47 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.2% | ||
| Years with dividends | 6 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +9.6% |
|---|---|
| 1 month | −28.0% |
| 3 months | −26.1% |
| 6 months | +3.8% |
| 1 year | +151.4% |
| 3 years | +1,047.9% |
| 5 years | +1,293.7% |
Signals
| 50-day / 200-day average | 1,629,001.57 / 1,480,021.71 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 93,747.33 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 Aug 2026 | KRW 375.0000 |
| 28 May 2026 | KRW 375.0000 |
| 26 Feb 2026 | KRW 1,875.0000 |
| 27 Nov 2025 | KRW 375.0000 |
| 28 Aug 2025 | KRW 375.0000 |
| 29 May 2025 | KRW 375.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Korea Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.